Real-world clinical outcomes of anticancer treatments and prognostic factors in patients with advanced melanoma in China
International Journal of Surgery Oncology · 2020-10 · 5 (5) · e97-e97
DOI: 10.1097/ij9.0000000000000097 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Surgery Oncology, 2020-10. Verfasst von Chuanliang Cui und 13 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-ND 4.0).
Abstract (Originalsprache)
Purpose
China has much lower 5-year survival rates among melanoma patients than Western countries. This retrospective study describes real-world clinical outcomes and prognostic factors in locally advanced/metastatic melanoma in China. Materials and methods: Adults patients with unresectable stage III or IV melanoma treated between January 1, 2014 and December 31, 2015, at the Beijing Cancer Hospital were eligible (data cutoff: December 31, 2017). The Kaplan-Meier method and Log-Rank test were used to estimate the median value of time-to-event outcomes. A Cox proportional hazards model was simulated to evaluate associations of patients’ characteristics with survival.
Results
Overall, there were 221 and 116 Chinese locally advanced and/or metastatic melanoma patients were enrolled in the first line (1L) and the second line (2L) treatments, respectively. The real-world objective response rate was
Zitieren
APA
Cui, C., Yan, X., Li, B., Si, L., Zhihong, C., Sheng, X., Lian, B., Wang, X., Mao, L., Tang, B., Zhou, L., Bai, X., Li, S., & Guo, J. (2020). Real-world clinical outcomes of anticancer treatments and prognostic factors in patients with advanced melanoma in China. International Journal of Surgery Oncology, 5(5), e97-e97. https://doi.org/10.1097/ij9.0000000000000097
Vancouver
Cui C, Yan X, Li B, Si L, Zhihong C, Sheng X, et al. Real-world clinical outcomes of anticancer treatments and prognostic factors in patients with advanced melanoma in China. International Journal of Surgery Oncology. 2020;5(5):e97-e97. doi:10.1097/ij9.0000000000000097
BibTeX
@article{Cui2020,
author = {Cui, Chuanliang and Yan, Xieqiao and Li, Ben and Si, Lu and Zhihong, Chi and Sheng, Xinan and Lian, Bin and Wang, Xuan and Mao, Lili and Tang, Bixia and Zhou, Li and Bai, Xue and Li, Siming and Guo, Jun},
title = {Real-world clinical outcomes of anticancer treatments and prognostic factors in patients with advanced melanoma in China},
journal = {International Journal of Surgery Oncology},
year = {2020},
volume = {5},
number = {5},
pages = {e97--e97},
doi = {10.1097/ij9.0000000000000097}
}
EUVIMED